Literature DB >> 9338002

Adeno-associated virus-mediated gene transfer into rat carotid arteries.

F Rolling1, Z Nong, S Pisvin, D Collen.   

Abstract

Gene transfer into the arterial wall may allow study of the role of specific genes in vascular pathophysiology and development of local gene therapies for vascular disorders. The feasibility of adeno-associated virus (AAV)-mediated gene transfer into isolated segments of normal and balloon-injured rat carotid arteries was studied using a recombinant AAV carrying CMVlacZ as a reporter gene. Approximately 10(6) and 10(7) infectious units (IU) of AAV were infused into 1 cm isolated segments of the carotid artery of 14 animals with the aid of a Silastic catheter and allowed to remain for 20 min. Animals were killed at different time-points after infection and arteries stained for beta-gal activity. Microscopic examination demonstrated comparable gene transfer into medial and adventitial cells, with significantly higher efficiency of transduction in injured as compared with normal vessels. High levels of in vivo beta-gal expression persisted for at least 30 days after gene transfer. Thus, AAV is capable of transducing media and adventitia of rat carotid arteries, suggesting that it may constitute a useful vector for arterial gene transfer and gene therapy protocols.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9338002     DOI: 10.1038/sj.gt.3300465

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  10 in total

Review 1.  Vectors for gene therapy of cardiovascular disease.

Authors:  J F Dedieu; A Mahfoudi; A Le Roux; D Branellec
Journal:  Curr Cardiol Rep       Date:  2000-01       Impact factor: 2.931

Review 2.  Cell physiology as a variable in gene transfer to endothelium.

Authors:  Philip L Leopold
Journal:  Curr Atheroscler Rep       Date:  2003-05       Impact factor: 5.113

3.  Gene transfer to intact mesenteric arteries by electroporation.

Authors:  J B Martin; J L Young; J N Benoit; D A Dean
Journal:  J Vasc Res       Date:  2000 Sep-Oct       Impact factor: 1.934

4.  A high-throughput biophotonics instrument to screen for novel ocular photosensitizing therapeutic agents.

Authors:  Mark C Butler; Patrick N Itotia; Jack M Sullivan
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-10-15       Impact factor: 4.799

5.  Adeno-associated virus-mediated transfer of endothelial nitric oxide synthase gene reduces the vasoconstrictive response.

Authors:  Y Maeda; U Ikeda; M Shimpo; S Ishibashi; T Takizawa; J Monahan; K Ozawa; K Shimada
Journal:  Exp Clin Cardiol       Date:  2001

Review 6.  In vivo tissue-tropism of adeno-associated viral vectors.

Authors:  Arun Srivastava
Journal:  Curr Opin Virol       Date:  2016-09-03       Impact factor: 7.090

7.  Strong foreign promoters contribute to innate inflammatory responses induced by adenovirus transducing vectors.

Authors:  Jerome Schaack; Michael L Bennett; Gary S Shapiro; James DeGregori; James L McManaman; John W Moorhead
Journal:  Virology       Date:  2011-01-20       Impact factor: 3.616

8.  Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie2.

Authors:  P Lin; J A Buxton; A Acheson; C Radziejewski; P C Maisonpierre; G D Yancopoulos; K M Channon; L P Hale; M W Dewhirst; S E George; K G Peters
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

9.  Efficient transduction of vascular smooth muscle cells with a translational AAV2.5 vector: a new perspective for in-stent restenosis gene therapy.

Authors:  A-M Lompré; L Hadri; E Merlet; Z Keuylian; N Mougenot; I Karakikes; J Chen; F Atassi; A Marchand; R Blaise; I Limon; S W J McPhee; R J Samulski; R J Hajjar; L Lipskaia
Journal:  Gene Ther       Date:  2013-03-28       Impact factor: 5.250

Review 10.  Drug- and Gene-eluting Stents for Preventing Coronary Restenosis.

Authors:  Kamali Manickavasagam Lekshmi; Hui-Lian Che; Chong-Su Cho; In-Kyu Park
Journal:  Chonnam Med J       Date:  2017-01-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.